Marsh & McLennan is delivering robust organic revenue growth, strong EPS beats and maintains a compelling dividend profile amid sector headwinds. MRSH trades at a forward P/E of 14.9, well below its 10-year average of 21.9, presenting a 26% discount to fair value. With an A- S&P rating, MRSH is positioned for continued bolt-on acquisitions and sustained dividend growth, targeting at least 9% annual increases.